A study led by a global research consortium offers new hope for patients with mycetoma, a neglected tropical disease.

The biotech will work on molecular glue degraders with Gilead in a new deal. Existing partner Sanofi changed its focus to a ...

Mitochondria have primarily been known as the energy-producing components of cells. But scientists are increasingly ...

Not only do mitochondria serve as the engine of the cell – they also act as watchtowers for the immune system.

WATERTOWN, Mass., June 25, 2025 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines ...

A groundbreaking study has revealed that a rare gene variant, APOE3-R136S, delays the onset of Alzheimer's disease by ...

Research on a cytokine called IL-17 adds new evidence that such molecules can influence behavior during illness.

ImmunityBio Inc. (NASDAQ:IBRX) is one of the 13 Best Long-Term Penny Stocks to Buy According to Analysts. On June 2, ...

Scientists have uncovered a stealthy tactic used by the SARS-CoV-2 virus: one of its proteins can leap from infected cells to ...

Corner Therapeutics, an immunotherapy company pioneering novel approaches to cancer and infection, today announced that its Distinguished Scientist, Scientific Co-founder and Board Member, Professor ...

Prostate cancer is one of the most common cancers and the second leading cause of cancer-related death in men worldwide. However, the mechanisms controlling the early stages of prostate cancer ...

A research team at the University of Münster has investigated for the first time how the confrontation of bacteria with hosts that have an activated innate immune system affects the evolution of ...